Skip to main content

Table 2 Subgroup analysis of the HBV pooled prevalence estimation in Ethiopia, 2019

From: An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia

Moderator variables Variable category Included studies Prevalence % (95% CI) I2% % P-value
Study group Blood donor 16 4 (0.03, 0.06) 98.99 0.00
Pregnant women 14 5 (0.04, 0.06 52.20 0.01
Healthcare worker 6 5 (0.05, 0.08) 89.47 0.00
HIV positive 7 5 (0.04, 0.07) 64.59 0.01
Others 17 9 (0.06, 0.11) 95.69 0.00
Study quality Good quality 50 5 (0.04, 0.06) 97.74 0.00
Poor quality 10 12 (0.07, 017) 98.12 0.00
Region/ city Amhara 22 4 (0.03, 0.05) 97.95 0.00
Oromia 12 6 (0.04, 0.09) 95.08 0.00
SNNPR 9 6 (0.04, 0.07) 67.13 0.00
Addis Ababa city 8 10 (0.06, 0.15) 96 0.00
Others 9 6 (0.04, 0.07) 95.77 0.00
Year of publication 2010–2012 5 4 (0.02, 0.05) 94.44 0.00
2013–2015 18 7 (0.05, 0.09) 94.85 0.00
2016–2019 37 6 (0.05, 0.07) 98.02 0.00
Year of study 2010–2012 12 5 (0.03, 0.06) 92.28 0.00
2013–2015 26 5 (0.05, 0.06) 85.59 0.00
2016–2019 12 6 (0.04, 0.07) 89.54 0.00
Sampling techniques Probability 20 5 (0.04, 0.06) 80.13 0.00
Non-probability 14 7 (0.05, 0.09) 89.56 0.00
Survey 20 6 (0.05, 0.07) 99.07 0.00
Not stated 6 5 (0.03, 0.06) 41.91 0.105
Diagnosis method ELISA 34 4 (0.04, 0.05) 97.98 0.00
RDT 21 8 (0.06, 0.10) 95.07 0.00
IA 4 8 (0.03, 0.13) 93.20 0.00
Setting Urban 39 6 (0.05, 0.07) 98.41 0.00
Mixed 21 5 (0.05, 0.06) 90.93 0.00
  1. Key: ELISA Enzyme-Linked Immunosorbent Assay, IA Immunoassay, RDT Rapid Diagnostic Test; SNNPR Southern Nations, Nationalities and Peoples Region